Search Images Maps Play YouTube News Gmail Drive More »
Settings | Sign in

Avastin

Avastin (bevacizumab) Analysis Market Research Report Now Available at Research Corridor

The Republic of East Vancouver - ‎Jul 28, 2016‎
Research Corridor has published a new research study titled “Avastin (bevacizumab) Analysis Market - Growth, Share, Opportunities, Competitive Analysis and Forecast, 2015 - 2022”.

Global & USA Cancer Immunotherapy Market Analysis to 2020 - Avastin, Nivolumab, Revlimid, Rituxan and Xtandi will ...

Business Wire (press release) - ‎Jul 26, 2016‎
It is forecast that by 2020, Avastin, Nivolumab, Revlimid, Rituxan and Xtandi will be the top five cancer drugs. A single drug, Bristol-Myers Squibb's Yervoy, for example has earned revenues of about $960 million in 2013 and it is expected to have a ...
See realtime coverage

Eye infection: PGI files plaint with drug controller

Hindustan Times - ‎Jul 17, 2016‎
The complaint includes a report prepared by Dr AK Jain, acting head, ophthalmology department; request for purchase of Avastin drug; and the cash memo showing that the drug was bought from a local chemist, Kumar and Company. (HT File ) ...

Les ratés de l'Avastin, ou comment passer à côté de grosses économies

Le Parisien - ‎Jul 17, 2016‎
Tout ça pour rien ? Les autorités de santé ont eu beau prendre le taureau par les cornes pour faciliter l'utilisation du très peu cher et très efficace médicament Avastin dans le traitement de la dégénérescence maculaire liée à l'âge (DMLA), les ...

L'Avastin sera radié partiellement de la liste en sus le 1er septembre 2016

Hospimedia (Abonnement) - ‎Jul 28, 2016‎
La FHP-MCO annonce, dans une dépêche, avoir appris le 27 juillet la radiation partielle de l'Avastin de la liste en sus au 1er août prochain. Dans une seconde dépêche, datée du 28 juillet, elle annonce avoir été informée d'un report de la radiation au ...

pSivida (PSDV) Announces Presentation of New Tethadur bioerodible Tech Data; Retained High Activity Noted

StreetInsider.com - ‎Jul 20, 2016‎
Dr. Catherine Kelly, Senior Scientist, presented the data from in vitro studies by pSivida led by Dr. Dinesh Nadarassan in a poster and an oral presentation entitled “Controlled Release of Avastin from the Tethadur Biodegradable Matrix” on July 19, 2016.

Understanding the Performance of Roche's Key Drugs

Market Realist - ‎Jul 24, 2016‎
Roche's (RHHBY) big-three drugs comprise of Herceptin, MabThera/Rituxan, and Avastin. Herceptin grew by 5% to 3.4 billion Swiss francs in the first half of 2016.

DMLA : le flop de l'avastin

Acuité - ‎Jul 19, 2016‎
Le passage en force du ministère de la Santé pour autoriser l'utilisation de l'Avastin dans le traitement de la DMLA n'aurait-il servi à rien ? C'est en tout cas ce qui ressort du rapport annuel de la Cnam (Caisse nationale d'assurance Maladie). Cette ...

Scorching Hot Biotech Stocks Tape: Cerus Corporation (CERS), CytRx Corporation (CYTR)

Zergwatch - ‎16 hours ago‎
Ms. Ware brings more than 20 years of biotechnology and pharmaceutical experience, including thirteen years at Genentech where she was responsible for key aspects of the launches of the oncology drugs Rituxan®, Herceptin® and Avastin®. While at ...

Centre seeks report from Chandigarh hospital after patients injected with drug complain of vision problems

Times of India - ‎Jul 20, 2016‎
NEW DELHI: The health ministry has asked for a detailed report from PGIMER (Postgraduate Institute of Medical Education and Research) Chandigarh after around 30 patients who were injected with Roche's Avastin for treatment of retinopathy last week, ...

Researchers Look to Refine Use of Radiation in Oligometastatic Lung Cancer

OncLive - ‎15 hours ago‎
Using radiation together with a VEGF-targeted agent, such as bevacizumab (Avastin), has associated toxicities that are much higher than what was expected.

Triplet Chemotherapy Treatment New Standard for Malignant Pleural Mesothelioma

MesotheliomaHelp.org (blog) - ‎Jul 25, 2016‎
In September 2015, when results of the Mesothelioma Avastin Plus Pemetrexed-cisplatin Study (MAPS) trial were reported at the 2015 World Conference on Lung Cancer, the lead author of the study said, “The treatment of pemetrexed, cisplatin, and ...

Tasquinimod prolongs radiographic PFS, not OS, in metastatic prostate cancer

Healio - ‎Jul 28, 2016‎
... KIT–specific antibodies, nitroaspirin, triterpenoid, all-trans retinoic acid, 25-hydroxyvitamin D3, gemcitabine, VEGF–trap, bevacizumab (Avastin, Genentech), doxorubicin, cyclophosphamide, antagonists of CXCR2 and CXCR4, sunitinib and PROK2 ...

Impure drug at PGI: No action taken yet

Times of India - ‎Jul 27, 2016‎
Chandigarh: After 30 patients in PGI, who were injected Roche's Avastin for treatment of retinopathy, reported adverse reactions on July 13, the drugs authorities in Chandigarh are yet to take samples of the contaminated batch.

New Mesothelioma Treatment Guidelines May Extend Survival

Asbestos.com - ‎Jul 26, 2016‎
Bevacizumab, also known by brand name Avastin, inhibits the formation of new blood vessels in tumors, effectively slowing the growth of cancer cells.

Top Biotechnology Stock Picking: Mast Therapeutics, Inc. (MSTX), CytRx Corporation (CYTR)

Zergwatch - ‎Jul 28, 2016‎
Ms. Ware brings more than 20 years of biotechnology and pharmaceutical experience, including thirteen years at Genentech where she was responsible for key aspects of the launches of the oncology drugs Rituxan®, Herceptin® and Avastin®. While at ...

7 Questions With a Medical Oncologist: Immunotherapy in Lung Cancer

Curetoday.com - ‎Jul 27, 2016‎
Meanwhile, other agents, such as Avastin (bevacizumab), Cyramza (ramucirumab), and Portrazza (necitumumab), among others, are also advancing the field.
See realtime coverage

Roche sales buoyed by cancer drugs

BioPharma Dive - ‎Jul 21, 2016‎
Overall group revenue hit 25,022 million Swiss francs (roughly $25.3 billion) through June 30. Sales of Rituxan, Herceptin, and Avastin—Roche's 'big three' cancer drugs—increased by mid-single digits, although Avastin fared worse in the U.S. market.

AstraZeneca plans Phase I trial with mRNA therapy for Cardiovascular Disease

Labiotech.eu (blog) - ‎Jul 27, 2016‎
Certain cancer drugs inhibit VEGF, such as Roche's Avastin. This therapy for cardiometabolic diseases does the opposite, instead raising the levels of growth factor.

Two Biotech Stocks Are Just So Hot Right Now: Puma Biotechnology, Inc. (PBYI), CytRx Corporation (CYTR)

Zergwatch - ‎Jul 27, 2016‎
Ms. Ware brings more than 20 years of biotechnology and pharmaceutical experience, including thirteen years at Genentech where she was responsible for key aspects of the launches of the oncology drugs Rituxan®, Herceptin® and Avastin®. While at ...
 -